What was Co-Diagnostics Inc’s price range in the past 12 months?
Co-Diagnostics Inc lowest share price was $1.00 and its highest was $1.79 in the past 12 months.
What is Co-Diagnostics Inc’s market cap?
Currently, no data Available
When is Co-Diagnostics Inc’s upcoming earnings report date?
Co-Diagnostics Inc’s upcoming earnings report date is May 09, 2024 which is in 14 days.
How were Co-Diagnostics Inc’s earnings last quarter?
Co-Diagnostics Inc released its earnings results on Mar 14, 2024. The company reported -$0.494 earnings per share for the quarter, missing the consensus estimate of -$0.2 by -$0.294.
Co-Diagnostics Inc does not currently pay dividends.
What is Co-Diagnostics Inc’s EPS estimate?
Co-Diagnostics Inc’s EPS estimate is -$0.21.
How many shares outstanding does Co-Diagnostics Inc have?
Co-Diagnostics Inc has 31,259,668 shares outstanding.
What happened to Co-Diagnostics Inc’s price movement after its last earnings report?
Co-Diagnostics Inc reported an EPS of -$0.494 in its last earnings report, missing expectations of -$0.2. Following the earnings report the stock price went down -7.802%.
Which hedge fund is a major shareholder of Co-Diagnostics Inc?
Among the largest hedge funds holding Co-Diagnostics Inc’s share is Hussman Strategic Advisors Inc. It holds Co-Diagnostics Inc’s shares valued at N/A.
Co-Diagnostics, Inc. is a molecular diagnostics company, which engages in the development, manufacture, and marketing of diagnostics technology. The company's products are utilized for tests that are designed using the detection and analysis of nucleic acid molecules. It also uses its proprietary technology to design tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.